Biomea Fusion Stockholders Vote on Key Proposals

Biomea Fusion ( (BMEA) ) has provided an announcement.

On June 11, 2025, Biomea Fusion held its Annual Meeting where stockholders voted on several key proposals. The election of three directors to the board was confirmed, and Deloitte & Touche LLP was ratified as the independent accounting firm for 2025. However, a proposal to amend the company’s Certificate of Incorporation to limit officer liability was not approved. Additionally, stockholders agreed to adjourn the meeting to gather more proxies for the unapproved amendment.

The most recent analyst rating on (BMEA) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Biomea Fusion stock, see the BMEA Stock Forecast page.

Spark’s Take on BMEA Stock

According to Spark, TipRanks’ AI Analyst, BMEA is a Underperform.

Biomea Fusion’s overall stock score is significantly impacted by its poor financial performance and bearish technical indicators. The company’s inability to generate revenue and negative cash flows are major concerns, despite a low debt level. The technical analysis further highlights a negative trend, with the stock trading below key moving averages. Lastly, the lack of positive valuation metrics, such as a negative P/E ratio and absence of a dividend yield, further depresses the score.

To see Spark’s full report on BMEA stock, click here.

More about Biomea Fusion

Average Trading Volume: 1,914,704

Technical Sentiment Signal: Hold

Current Market Cap: $93.93M

For an in-depth examination of BMEA stock, go to TipRanks’ Overview page.